338 related articles for article (PubMed ID: 18312972)
21. Treatment of upper gum carcinoma with high-dose-rate customized-mold brachytherapy.
Garrán C; Montesdeoca N; Martínez-Monge R
Brachytherapy; 2008; 7(3):267-9. PubMed ID: 18635026
[TBL] [Abstract][Full Text] [Related]
22. External and intracavitary radiotherapy in the management of carcinoma of extrahepatic biliary tract.
Trodella L; Mantini G; Barina M; Montemaggi P
Rays; 1991; 16(1):71-5. PubMed ID: 1646464
[No Abstract] [Full Text] [Related]
23. An accurate method of 192Ir wire implantation for locally advanced carcinoma of breast.
Teo P; Chung D
Acta Oncol; 1987; 26(4):273-6. PubMed ID: 3120759
[TBL] [Abstract][Full Text] [Related]
24. Single versus customized treatment planning for image-guided high-dose-rate brachytherapy for cervical cancer: dosimetric comparison and predicting factor for organs at risk overdose with single plan approach.
Chi A; Gao M; Sinacore J; Nguyen NP; Vali F; Albuquerque K
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):309-14. PubMed ID: 19540070
[TBL] [Abstract][Full Text] [Related]
25. Comparison of air kerma standards of LNE-LNHB and NPL for 192Ir HDR brachytherapy sources: EUROMET project no 814.
Douysset G; Sander T; Gouriou J; Nutbrown R
Phys Med Biol; 2008 Mar; 53(6):N85-97. PubMed ID: 18367784
[TBL] [Abstract][Full Text] [Related]
26. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
Demanes DJ; Brandt D; Schour L; Hill DR
Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
[TBL] [Abstract][Full Text] [Related]
27. High dose rate treatment of a maxillary sarcomatoid carcinoma: a case report.
Asbury L; Candelaria S; Rudak F; Stutzman CD; Lake DE
Med Dosim; 1992; 17(3):129-33. PubMed ID: 1388677
[TBL] [Abstract][Full Text] [Related]
28. [First experience with a line source in gynecologic after-loading therapy].
Bauer N; Tode D; Kaufhold S; Tode G
Radiobiol Radiother (Berl); 1988; 29(1):51-8. PubMed ID: 3387535
[No Abstract] [Full Text] [Related]
29. Effect of high-dose-rate 192Ir source activity on late rectal bleeding after intracavitary radiation therapy for uterine cervix cancer.
Suzuki O; Yoshioka Y; Isohashi F; Morimoto M; Kotsuma T; Kawaguchi Y; Konishi K; Nakamura S; Shiomi H; Inoue T
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1329-34. PubMed ID: 18439763
[TBL] [Abstract][Full Text] [Related]
30. [Radiometric methods of calibrating high dose iridium (192Ir) brachytherapy].
Milosević NT; Stanković JB; Dabić-Stanković K
Vojnosanit Pregl; 2003; 60(4):479-85. PubMed ID: 12958808
[No Abstract] [Full Text] [Related]
31. Treatment of regional cutaneous nodular metastases from melanoma using high-dose rate mould brachytherapy.
Chaudhuri A; De-Groot C; Seel M; Jolly M; Cameron T
J Med Imaging Radiat Oncol; 2011 Apr; 55(2):206-12. PubMed ID: 21501412
[TBL] [Abstract][Full Text] [Related]
32. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
[TBL] [Abstract][Full Text] [Related]
33. Critical organ preservation in reirradiation brachytherapy by injectable spacer.
Kishi K; Sonomura T; Shirai S; Sato M; Tanaka K
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):587-94. PubMed ID: 19735885
[TBL] [Abstract][Full Text] [Related]
34. Comparison of 60cobalt and 192iridium sources in high dose rate afterloading brachytherapy.
Richter J; Baier K; Flentje M
Strahlenther Onkol; 2008 Apr; 184(4):187-92. PubMed ID: 18398582
[TBL] [Abstract][Full Text] [Related]
35. [Brachytherapy in the treatment of lung and tracheal cancer: current indications, methods, results].
Skowronek J; Młynarczyk W; Piorunek T
Przegl Lek; 2006; 63(8):664-73. PubMed ID: 17441380
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.
Fang FM; Wang YM; Wang CJ; Huang HY; Chiang PH
Jpn J Clin Oncol; 2008 Jul; 38(7):474-9. PubMed ID: 18621848
[TBL] [Abstract][Full Text] [Related]
37. Response of an implantable MOSFET dosimeter to 192Ir HDR radiation.
Fagerstrom JM; Micka JA; DeWerd LA
Med Phys; 2008 Dec; 35(12):5729-37. PubMed ID: 19175130
[TBL] [Abstract][Full Text] [Related]
38. Reference dose rates for single- and double-plane 192Ir implants.
Saw CB; Suntharalingam N
Med Phys; 1988; 15(3):391-6. PubMed ID: 3405143
[TBL] [Abstract][Full Text] [Related]
39. Radiation therapy verification in brachytherapy combining iron sulphate gel irradiation and magnetic resonance imaging (MRI).
Busch M; Matthaei D; Rave-Fränk M; Mäurer J; Dühmke E
Strahlenther Onkol; 1993 Mar; 169(3):168-70. PubMed ID: 8465251
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of dosimetric parameters for various 192Ir brachytherapy sources under unbounded phantom geometry by Monte Carlo simulation.
Devan K; Aruna P; Manigandan D; Bharanidharan G; Subbaiah KV; Sunny CS; Ganesan S
Med Dosim; 2007; 32(4):305-15. PubMed ID: 17980833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]